Published in Tuberculosis Week, March 22nd, 2010
"These compounds have been screened for their in vitro activity against Mycobacterium tuberculosis H37Rv (MTB) using agar dilution method. Among the twenty two compounds screened, (3S,4S,5R)-3,4-di(4-methylphenyl)-2-phenyl-7-[®-1-phenylethyl]-1-oxa-2,7-diazaspiro[4.5]decan-10-one (3e) was found to possess the maximum activity with MIC of 3.02 mc M, being 2.5 times more potent than the first-line...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week